We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




PCL Alverno to Implement Beckman Coulter's Expertise

By LabMedica International staff writers
Posted on 25 Feb 2014
Print article
PCL Alverno Clinical Laboratories (Hammond, IN, USA) and Beckman Coulter Diagnostics (Brea, CA, USA) announced a partnership to create laboratories to better serve patients. Beckman Coulter was awarded an installation agreement by PLC Alverno with the aim of improving the clinical laboratory.

The contract includes a hematology extension of the laboratory network’s current only source agreement, a new Iris urinalysis agreement, AU chemistry instruments, DxI immunoassay instruments, and four automation lines.

PCL Alverno is a full service, community-based medical laboratory performing over 750 tests in both clinical and anatomic pathology. It is joint venture of two distinct Catholic healthcare systems: Presence Health (IL, USA) and Franciscan Alliance (IN, USA). PCL Alverno provides laboratory services for 26 hospitals in Indiana and Illinois and has a large reference lab for outreach work. Its modern state-of-the-art laboratory is a freestanding, local reference lab in its service area. PCL Alverno offers the personal customer service of a local laboratory with the style of a large reference laboratory. PCL Alverno's pathologists are part of the pathology practice of Pathology Consultants, Inc.

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. PCL Alverno will modernize their laboratories with more than 150 new instruments beginning in 2014, implementing Beckman Coulter’s automation solutions and expertise in workflow processes.

“We are honored that PCL Alverno has chosen to partner with Beckman Coulter Diagnostics to provide solutions that deliver quality results through automation and standardized workflow processes in the laboratory,” said John Nosenzo, senior vice president of Global Customer Operations, Beckman Coulter Diagnostics. “This partnership demonstrates our shared commitment to patient care and allows us the opportunity to jointly advance and optimize the laboratory—the foundation of patient care.”

Related Links:

PCL Alverno Clinical Laboratories
Beckman Coulter Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.